Dr Daniel Tillett
Dr Daniel Tillett is Managing Director and Chief Executive Officer of Racura Oncology. He has more than 25 years of management experience in the biotechnology industry, with expertise spanning commercial strategy, IP management, sales and marketing, project management, licensing and fundraising.
Contact info
- Website:
- https://racuraoncology.com/
ArticleWhy researchers are revisiting bisantrene decades after it was abandoned
An oncology drug abandoned decades ago is getting a second look, with new research uncovering a mechanism that could offer an alternative route to targeting MYC, one of cancer’s toughest targets.